Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion.
El Fassi
Daniel
D
Nielsen
Claus H
CH
Hasselbalch
Hans C
HC
Hegedüs
Laszlo
L
D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D058846:Antibodies, Monoclonal, Murine-Derived; D013956:Antithyroid Agents / Q000494:pharmacology; D001323:Autoantibodies / Q000494:pharmacology; D001402:B-Lymphocytes / Q000378:metabolism*; D005260:Female; D005938:Glucocorticoids / Q000378:metabolism; D006111:Graves Disease / Q000473:pathology*; D049970:Graves Ophthalmopathy / Q000628:therapy*; D006801:Humans; D018828:Immunoglobulins, Thyroid-Stimulating; D008713:Methimazole / Q000494:pharmacology; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D000069283:Rituximab; D013959:Thyroid Diseases / Q000628:therapy
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D013956:Antithyroid Agents; D001323:Autoantibodies; D005938:Glucocorticoids; D018828:Immunoglobulins, Thyroid-Stimulating; C094372:thyrotropin-binding inhibitory immunoglobulin; D000069283:Rituximab; D008713:Methimazole